By Professor Glenda Halliday

Journal articles

Huang Y; Halliday GM, 2012, 'Aspects of innate immunity and Parkinson's disease', Frontiers in Pharmacology, 3, pp. Art. No. 33, http://dx.doi.org/10.3389/fphar.2012.00033

Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok J, 2012, 'C9ORF72 repeat expansion in clinical and neuropathological frontotemporal dementia cohorts', Neurology, 79, pp. 995 - 1001

Kim WS; Halliday , 2012, 'Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression', Journal of Parkinson's Disease, 2, pp. 41 - 46, http://dx.doi.org/10.3233/JPD-2012-11059

Halliday GM; Mccann H; Shepherd CE, 2012, 'Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?', Expert Review of Neurotherapeutics, 12, pp. 673 - 686, http://dx.doi.org/10.1586/ern.12.47

Reyes S; Fu Y; Double KL; Thompson L; Kirik D; Paxinos G; Halliday GM, 2012, 'GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area', Journal of Comparative Neurology, 520, pp. 2591 - 2607, http://dx.doi.org/10.1002/cne.23051

Hornberger M; Wong S; Tan R; Irish M; Piguet O; Kril J; Hodges JR; Halliday GM, 2012, 'In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease', Brain, 135, pp. 3015 - 3025, http://dx.doi.org/10.1093/brain/aws239

Shine JM; Halliday GM; Carlos M; Lewis SJG; Naismith S, 2012, 'Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm', Movement Disorders, 27, pp. 500 - 505, http://dx.doi.org/10.1002/mds.24900

Sharpe LJ; Wong J; Garner B; Halliday GM; Brown AJ, 2012, 'Is seladin-1 really a selective Alzheimer's disease indicator?', Journal of Alzheimer's Disease, 30, pp. 35 - 39, http://dx.doi.org/10.3233/JAD-2012-111955

Elliott DA; Kim WS; Gorissen SV; Halliday GM; Kwok J, 2012, 'Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease', Movement Disorders, 27, pp. 1004 - 1011, http://dx.doi.org/10.1002/mds.25005

Halliday GM; Bigio EH; Cairns NJ; Neumann M; Mackenzie IRA; Mann DM, 2012, 'Mechanisms of disease in frontotemporal lobar degeneration: Gain of function versus loss of function effects', ACTA Neuropathologica, 124, pp. 373 - 382, http://dx.doi.org/10.1007/s00401-012-1030-4

Valenzuela MJ; Matthews F; Brayne C; Ince P; Halliday GM; Kril J; Dalton M; Richardson K; Forster G; Sachdev PS, 2012, 'Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia', Biological Psychiatry, 71, pp. 783 - 791, http://dx.doi.org/10.1016/j.biopsych.2011.07.036

Wong J; Garner B; Halliday G; Kwok J, 2012, 'P4‐372: Evidence of altered TrkB pre‐mRNA splicing in Alzheimer's disease', Alzheimer's & Dementia, 8, http://dx.doi.org/10.1016/j.jalz.2013.08.153

Kavanagh T; Mills JD; Kim WS; Halliday GM; Janitz M, 2012, 'Pathway analysis of the human brain transcriptome in disease', Journal of Molecular Neuroscience, Published online, http://dx.doi.org/10.1007/s12031-012-9940-0

Stevens CH; Rowe DB; Morel-Kopp MC; Orr CF; Russell T; Ranola M; Ward CM; Halliday GM, 2012, 'Reduced T helper and B lymphocytes in Parkinson's disease', Journal of Neuroimmunology, 252, pp. 95 - 99, http://dx.doi.org/10.1016/j.jneuroim.2012.07.015

Lim YA; Giese M; Shepherd CE; Halliday GM; Kobayashi M; Takamatsu K; Staufenbiel M; Eckert A; Gotz J, 2012, 'Role of hippocalcin in mediating Abeta toxicity', Biochimica et Biophysica ACTA - Molecular Basis of Disease, 1822, pp. 1247 - 1257, http://dx.doi.org/10.1016/j.bbadis.2012.04.007

Schwartz RS; Halliday GM; Cordato DJ; Kril JJ, 2012, 'Small-vessel disease in patients with Parkinson's disease: A clinicopathological study', Movement Disorders, 27, pp. 1506 - 1512, http://dx.doi.org/10.1002/mds.25112

Wong JCY; Garner B; Halliday GM; Kwok JBJ, 2012, 'Srp20 regulates TrkB pre-mRNA splicing to generate TrkB-Shc transcripts with implications for Alzheimer's disease', Journal of Neurochemistry, 123, pp. 159 - 171, http://dx.doi.org/10.1111/j.1471-4159.2012.07873.x

Schofield E; Hodges JR; Bak T; Xuereb JH; Halliday GM, 2012, 'The relationship between clinical and pathological variables in Richardson's syndrome', Journal of Neurology, 259, pp. 482 - 490, http://dx.doi.org/10.1007/s00415-011-6205-8

Farrell AW; Halliday GM; Lyons JG, 2011, 'Chromatin structure following UV-induced DNA damage-repair or death?', International Journal of Molecular Sciences, 12, pp. 8063 - 8085, http://dx.doi.org/10.3390/ijms12118063

Byrne SN; Beaugie C; O'Sullivan C; Leighton S; Halliday GM, 2011, 'The Immune-Modulating Cytokine and Endogenous Alarmin Interleukin-33 Is Upregulated in Skin Exposed to Inflammatory UVB Radiation', AMERICAN JOURNAL OF PATHOLOGY, 179, pp. 211 - 222, http://dx.doi.org/10.1016/j.ajpath.2011.03.010

Bock VL; Lyons JG; Huang XXJ; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM, 2011, 'BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours', British Journal of Dermatology, 164, pp. 1221 - 1227, http://dx.doi.org/10.1111/j.1365-2133.2011.10267.x

Damian DL; Matthews YJ; Phan TA; Halliday GM, 2011, 'An action spectrum for ultraviolet radiation-induced immunosuppression in humans', British Journal of Dermatology, 164, pp. 657 - 659, http://dx.doi.org/10.1111/j.1365-2133.2010.10161.x

Zhou J; Broe M; Huang Y; Anderson JA; Gai WP; Milward EA; Porritt MJ; Howells DW; Hughes AJ; Wang X; Halliday GM, 2011, 'Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease', ACTA Neuropathologica, 121, pp. 695 - 704, http://dx.doi.org/10.1007/s00401-011-0815-1

Sachdev PS; Lee T; Lammel A; Crawford J; Trollor JN; Wright MJ; Brodaty H; Ames D; Martin NG, 2011, 'Cognitive functioning in older twins: The Older Australian Twins Study', Australasian Journal on Ageing, 30, pp. 17 - 23, http://dx.doi.org/10.1111/j.1741-6612.2011.00534.x

Chen-Plotkin A; Martinez-Lage M; Sleiman PMA; Hu W; Greene R; Wood EF; Bing S; Grossman M; Schellenberg GD; Hatanpaa K; Weiner M; White III CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach T; Graff-radford N; Dickson D; Rademakers R; Boeve B; Pickering-Brown SM; Snowden J; Van Swieten JC; Heutink P; Seelaar H; Murrell J; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio EH; Llado A; Miller B; Alzualde A; Moreno FS; Rohrer JD; Mackenzie IRA; Feldman H; Hamilton RL; Cruts M; Engelborghs ; De Deyn PP; Van Broeckhoven C; Bird T; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van deerlin VM, 2011, 'Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration', Archives of Neurology, 68, pp. 488 - 497

Halliday GM; Stevens C, 2011, 'Glia: Initiators and progressors of pathology in Parkinson's disease', Movement Disorders, 26, pp. 6 - 17, http://dx.doi.org/10.1002/23455

Huang Y; Rowe DB; Halliday , 2011, 'Interaction between a-synuclein and tau genotypes and the progression of Parkinson's disease', Journal of Parkinson's Disease, 1, pp. 271 - 276, http://dx.doi.org/10.3233/JPD-2011-11027

Masters CL; Kril J; Halliday GM; Pamphlett R; Collins S; Hill AF; McLean CA, 2011, 'Overview and recent advances in neuropathology. Part 2: Neurodegeneration', Pathology, 43, pp. 93 - 102, http://dx.doi.org/10.1097/PAT.0b013e3283426eee

Dobson‐Stone C; Luty A; Hallupp M; Coupland K; Brooks W; Panegyres P; Piguet O; Broe GA; Sobow T; Zekanowski C; Halliday G; Schofield P; Kwok J, 2011, 'P1‐285: Sigma non‐opioid intracellular receptor 1 and neurodegeneration: prevalence of mutations and therapeutic implications', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.566

Kwok J; Luty A; Dobson‐Stone C; Loy C; Brooks W; Karlström H; Halliday G; Schofield P, 2011, 'P1‐287: Positional cloning identifies SIGMAR1 gene as a causative locus for FTLD‐MND in a large Australian pedigree', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.568

Kril J; Halliday GM, 2011, 'Pathological staging of frontotemporal lobar degeneration', Journal of Molecular Neuroscience, 45, pp. 379 - 383, http://dx.doi.org/10.1007/s12031-011-9528-0

Komadina N; Terpening Z; Huang Y; Halliday GM; Lewis SJG; Naismith S, 2011, 'Utility and limitations of Addenbrooke's cognitive examination-revised for detecting mild cognitive impairment in Parkinson's disease', Dementia and Geriatric Cognitive Disorders, 31, pp. 349 - 357, http://dx.doi.org/10.1159/000328165

Shine JM; Halliday GM; Lewis SJG; Naismith S, 2011, 'Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?', Movement Disorders, 26, pp. 2154 - 2159, http://dx.doi.org/10.1002/mds.23896

Sou PW; Delic NC; Halliday GM; Lyons JG, 2010, 'Snail transcription factors in keratinocytes: Enough to make your skin crawl', International Journal of Biochemistry and Cell Biology, 42, pp. 1940 - 1944, http://dx.doi.org/10.1016/j.biocel.2010.08.021

Gabery S; Murphy K; Schultz K; Loy C; McCusker E; Kirik D; Halliday G; Petersen A, 2010, 'CHANGES IN KEY HYPOTHALAMIC NEUROPEPTIDE POPULATIONS IN HUNTINGTON'S DISEASE REVEALED BY NEUROPATHOLOGICAL ANALYSES', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, pp. A7 - A8, http://dx.doi.org/10.1136/jnnp.2010.222570.23

Huang Y; Zheng L; Halliday G; Dobson-Stone C; Wang YY; Tang HD; Kowk J; Chen SD, 2010, '78. Genetic influences of sigma-1 receptor and apolipoprotein E on the severity of Alzheimer’s disease', Journal of Clinical Neuroscience, 17, pp. 1633 - 1633, http://dx.doi.org/10.1016/j.jocn.2010.07.079

Van deerlin VM; Sleiman PMA; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DMA; Pickering-Brown SM; Seelaar H; Heutink P; Van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges JR; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; al-Sarraj S; Troakes C; Rosenberg RN; White III CL; Ferrer I; Llado A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JL; Hardy J; Rohrer JD; Lashley T; Mackenzie IRA; Feldman HH; Hamilton RL; Dekosky ST; Van der zee ST; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel ; Troncoso JC; Kril JJ; Bird T; Halliday GM; Ince PG; Shaw PA; Kwok JB; Cairns NJ; Morris JC; Mclean ; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Perl DP; Sano DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller ; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman E; Tunon MT; Martinez MCC; Munoz DG; Carroll SL; Marson SL; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Tronjanowski JQ; Lee VMY, 2010, 'Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions', Nature Genetics, 42, pp. 234 - 239

Mitew S; Kirkcaldie MTK; Halliday GM; Shepherd CE; Vickers JC; Dickson TC, 2010, 'Focal demyelination in Alzheimer's disease and transgenic', ACTA Neuropathologica, 119, pp. 567 - 577

Ma M; Huang Y; Chen S; Halliday GM, 2010, 'Immunohistochemical evidence for macroautophagy in neurons and endothelial cells in Alzheimer's disease', Neuropathology and Applied Neurobiology, 36, pp. 312 - 319

Kim WS; Bhatia S; Elliott DA; Agholme L; Kagedal K; Mccann H; Halliday GM; Barnham K; Garner B, 2010, 'Increased ATP-binding cassette trabsporter A1 expression in Alzheimer's disease hippocampal neurons', Journal of Alzheimer's Disease, 21, pp. 193 - 205

Kagedal K; Kim WS; Appelqvist A; Chan LL; Cheng D; Agholme L; Barnham K; Mccann H; Halliday GM; Garner B, 2010, 'Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease', Biochimica et Biophysica ACTA - Molecular and Cell Biology of Lipids, 1801, pp. 831 - 838

Schofield E; Halliday GM; Kwok J; Loy C; Double KL; Hodges JR, 2010, 'Low serum progranulin predicts the presence of mutations: a prospective study', Journal of Alzheimer's Disease, 22, pp. 981 - 984

Obeso J; Rodriguez-oroz M; Goetz CG; Marin C; Kordower J; Rodriguez M; Hirsch E; Farrer M; Schapira A; Halliday GM, 2010, 'Missing pieces in the Parkinson's disease puzzle', Nature Medicine, 16, pp. 653 - 661

Mackenzie IRA; Neumann M; Bigio EH; Cairns NJ; Alafuzoff I; Kril J; Kovacs G; Ghetti B; Halliday GM; Holm IE; Ince PG; Kamphorst W; Revesz T; Rozemuller AJM; Kumar-Singh S; Akiyama H; Baborie A; Spina S; Dickson D; Trojanowski JQ; Mann DMA, 2010, 'Nomenclature and nosology for neurophathologic subtypes of frontotemporal lobar degeneration: an update', ACTA Neuropathologica, 119, pp. 1 - 4

Kågedal K; Kim W; Appelqvist H; Chan S; Cheng D; Hellström L; Barnham K; McCann H; Halliday G; Garner B, 2010, 'P4‐153: Increased Expression of the Lysosomal Cholesterol Transporter NPC1 in Alzheimer's Disease', Alzheimer's & Dementia, 6, http://dx.doi.org/10.1016/j.jalz.2010.08.212

Double KL; Halliday GM; Dunkley PR; Dickson PW; Gerlach M; Riederer P, 2010, 'Pigmentation in the Human Brain and Risk of Parkinson's Disease', Annals of Neurology, 67, pp. 553 - 553

Loy CT; Jillian JK; Trollor JN; Kiernan MC; Kwok J; Vucic O; Halliday GM; Hodges JR, 2010, 'The case of a 48 year-old woman with bizarre and complex delusions', Nature Reviews Neurology, 6, pp. 175 - 179, http://www.nature.com/nrneurol/journal/v6/n3/abs/nrneurol.2010.3.html

Halliday GM; Mccann H, 2010, 'The progression of pathology in Parkinson's disease', Annals of the New York Academy of Sciences, 1184, pp. 188 - 195

Loy C; McCusker E; Kril J; Kwok J; Brooks WS; Mccann H; Isaacs A; Halliday GM, 2010, 'Very early onset frontotemporal dementia with no family history preducts underlying fused in sarcoma pathology', Brain, 133, pp. e158, http://dx.doi.org/10.1093/brain/awq186

Shehadeh J; Double K; Murphy K; Bobrovskaya L; Reyes S; Dunkley P; Dickson P; Halliday G, 2009, 'Differential distribution of tyrosine hydroxylase isoforms in the human brain', PARKINSONISM & RELATED DISORDERS, 15, pp. S164 - S164, http://dx.doi.org/10.1016/S1353-8020(09)70625-X

Back to profile page